Hematological Tumor - Pipeline Review, H1 2014


Published on

Market Research Reports, Inc. has announced the addition of “Hematological Tumor - Pipeline Review, H1 2014” research report to their offering. See more at- http://mrr.cm/ZWx

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Hematological Tumor - Pipeline Review, H1 2014

  1. 1. www.MarketResearchReports.com Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. www.MarketResearchReports.com Introduction to Report  Launch Date: June 30, 2014  Number of Pages: 450  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 2,000 Price For Site License: USD 4,000 Price For Global User License: USD 6,000 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. www.MarketResearchReports.com About the Report This Report provides an overview of the Hematological Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hematological Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hematological Tumor and special features on late-stage and discontinued projects.
  4. 4. www.MarketResearchReports.com Research Finding Publisher’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
  5. 5. www.MarketResearchReports.com Scope The report provides a snapshot of the global therapeutic landscape of Hematological Tumor The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Hematological Tumor and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Hematological Tumor products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  6. 6. www.MarketResearchReports.com Scope Continues… Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Hematological Tumor pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products
  7. 7. www.MarketResearchReports.com Report Coverage 1. Introduction 2. Hematological Tumor Overview 3. Therapeutics Development 4. Clinical Stage Products 5. Drug Profiles 6. Appendix 7. Methodology For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  8. 8. www.MarketResearchReports.com Company Coverage (Partial List) 1. F. Hoffmann-La Roche Ltd. 2. AstraZeneca PLC 3. Eli Lilly and Company 4. GlaxoSmithKline plc 5. MedImmune, LLC 6. Gilead Sciences, Inc. 7. Merck & Co., Inc. 8. AbGenomics International, Inc. 9. Dainippon Sumitomo Pharma Co., Ltd. 10.Gamida Cell Ltd. 11.Infinity Pharmaceuticals, Inc. 12.Symphogen A/S For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  9. 9. www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center
  10. 10. www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/ZWx About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India)